References
- Austin MA, Hutter CM, Zimmern RL, et al. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. American Journal of Epidemiology 2004;160:421-429.
- Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3-46.
- Familial Hypercholesterolemia. A report of a WHO consultation. WHO. Geneva, Switzerland, 1998.
- Myśliwiec M, Walczak M, Małecka-Tendera E, el al. Stanowisko dotyczące postępowania w rodzinnej hipercholesterolemii u dzieci i młodzieży. Stanowisko Forum Ekspertów Lipidowych. Pediatria Polska 2013;88:567-574.
- Jourdan C, Wühl E, Litwin M, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. Journal of Hypertension 2005;23:1707-1715.
- Calabro MP, Carej S, Russo MS, et al. Normal paediatric values of arterial stiffness parameters measured by echo-tracking. The child, a Journal of Pediatrics 2012;Vol 1, No. 1.
- Wiegman A, Hutten BA, De Groot E, et al. E' cacy and safety of statin therapy in children with familial hypercholesterolemia. A randomized controlled trial. Jama 2004; 292(3):331-337.
- Joyce L Ross. Statins in the Management of Pediatric. Journal of Pediatric Nursing 2016.
- Nordestgaard BD, Chapman MJ, Humphires SE. Familial hypercholestaerolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. European Heart Journal 2013;34:3478-3490.
- Undas A, pod red. Podolec P. Zaburzenia lipidowe − kogo i kiedy należy objąć badaniem przesiewowym. Podręcznik Polskiego Forum Pro#laktyki T.2. Kraków: Med Prakt. 2010.
- Walldius G, Aastveit AH, Junger I. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. Journal of Internal Medicine 2006;259:259-266.
- Riggio S, Mandra' no G, Sardo MA, et al. Pulse wave velocity and augumentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest. 2010;40(3):250-257.
- Sobień B, Kopeć G, Podolec P. Statyny. Podręcznik Polskiego Forum Pro#laktyki T.2. Kraków: Med Prakt. 2010.
- Kamińska E, Hennig M, Brandt A, Bautembach Minkowska J, Myśliwiec M. Treatment with statins in children with familial hypercholesterolemia,Developmental Period Medicine 2016;XX;4:328-334.